{"id":"https://openalex.org/W2159214533","doi":"https://doi.org/10.1158/0008-5472.can-13-1646","title":"Combined Anti-CD40 and Anti\u2013IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases","display_name":"Combined Anti-CD40 and Anti\u2013IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases","alternate_titles":[],"publication_year":2014,"publication_date":"2014-04-30","ids":{"openalex":"https://openalex.org/W2159214533","doi":"https://doi.org/10.1158/0008-5472.can-13-1646","mag":"2159214533","pmid":"https://pubmed.ncbi.nlm.nih.gov/24556719"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-13-1646","doi":"https://doi.org/10.1158/0008-5472.can-13-1646","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-13-1646","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2159214533"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084723072","display_name":"Bianca von Scheidt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bianca von Scheidt","raw_affiliation_strings":["Authors' Affiliations:\u20081Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 3Immunology in Cancer and Infection Laboratory; 4Cancer Immunoregulation and Immunotherapy Laboratory, Queensland Institute of Medical Research; 5School of Medicine, University of Queensland, Herston, Queensland, Australia; and 6AMGEN Incorporated, Seattle, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 3Immunology in Cancer and Infection Laboratory; 4Cancer Immunoregulation and Immunotherapy Laboratory, Queensland Institute of Medical Research; 5School of Medicine, University of Queensland, Herston, Queensland, Australia; and 6AMGEN Incorporated, Seattle, Washington","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I165779595","https://openalex.org/I217937681","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083552057","display_name":"Patrick S.K. Leung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patrick S.K. Leung","raw_affiliation_strings":["Authors' Affiliations:\u20081Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 3Immunology in Cancer and Infection Laboratory; 4Cancer Immunoregulation and Immunotherapy Laboratory, Queensland Institute of Medical Research; 5School of Medicine, University of Queensland, Herston, Queensland, Australia; and 6AMGEN Incorporated, Seattle, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 3Immunology in Cancer and Infection Laboratory; 4Cancer Immunoregulation and Immunotherapy Laboratory, Queensland Institute of Medical Research; 5School of Medicine, University of Queensland, Herston, Queensland, Australia; and 6AMGEN Incorporated, Seattle, Washington","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I165779595","https://openalex.org/I217937681","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084455630","display_name":"Michelle C.R. Yong","orcid":"https://orcid.org/0009-0002-0450-5236","observed_orcids":["https://orcid.org/0009-0002-0450-5236"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michelle C.R. Yong","raw_affiliation_strings":["Authors' Affiliations:\u20081Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 3Immunology in Cancer and Infection Laboratory; 4Cancer Immunoregulation and Immunotherapy Laboratory, Queensland Institute of Medical Research; 5School of Medicine, University of Queensland, Herston, Queensland, Australia; and 6AMGEN Incorporated, Seattle, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 3Immunology in Cancer and Infection Laboratory; 4Cancer Immunoregulation and Immunotherapy Laboratory, Queensland Institute of Medical Research; 5School of Medicine, University of Queensland, Herston, Queensland, Australia; and 6AMGEN Incorporated, Seattle, Washington","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I165779595","https://openalex.org/I217937681","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100433684","display_name":"Yu Xin Zhang","orcid":"https://orcid.org/0000-0003-0978-2363","observed_orcids":["https://orcid.org/0000-0003-0978-2363"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yu Zhang","raw_affiliation_strings":["Authors' Affiliations:\u20081Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 3Immunology in Cancer and Infection Laboratory; 4Cancer Immunoregulation and Immunotherapy Laboratory, Queensland Institute of Medical Research; 5School of Medicine, University of Queensland, Herston, Queensland, Australia; and 6AMGEN Incorporated, Seattle, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 3Immunology in Cancer and Infection Laboratory; 4Cancer Immunoregulation and Immunotherapy Laboratory, Queensland Institute of Medical Research; 5School of Medicine, University of Queensland, Herston, Queensland, Australia; and 6AMGEN Incorporated, Seattle, Washington","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I165779595","https://openalex.org/I217937681","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088670790","display_name":"Jennifer E. Towne","orcid":"https://orcid.org/0000-0002-7943-7453","observed_orcids":["https://orcid.org/0000-0002-7943-7453"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jennifer E. Towne","raw_affiliation_strings":["Authors' Affiliations:\u20081Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 3Immunology in Cancer and Infection Laboratory; 4Cancer Immunoregulation and Immunotherapy Laboratory, Queensland Institute of Medical Research; 5School of Medicine, University of Queensland, Herston, Queensland, Australia; and 6AMGEN Incorporated, Seattle, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 3Immunology in Cancer and Infection Laboratory; 4Cancer Immunoregulation and Immunotherapy Laboratory, Queensland Institute of Medical Research; 5School of Medicine, University of Queensland, Herston, Queensland, Australia; and 6AMGEN Incorporated, Seattle, Washington","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I165779595","https://openalex.org/I217937681","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061575707","display_name":"Mark John Smyth","orcid":"https://orcid.org/0000-0001-7098-7240","observed_orcids":["https://orcid.org/0000-0001-7098-7240"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark J. Smyth","raw_affiliation_strings":["Authors' Affiliations:\u20081Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 3Immunology in Cancer and Infection Laboratory; 4Cancer Immunoregulation and Immunotherapy Laboratory, Queensland Institute of Medical Research; 5School of Medicine, University of Queensland, Herston, Queensland, Australia; and 6AMGEN Incorporated, Seattle, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 3Immunology in Cancer and Infection Laboratory; 4Cancer Immunoregulation and Immunotherapy Laboratory, Queensland Institute of Medical Research; 5School of Medicine, University of Queensland, Herston, Queensland, Australia; and 6AMGEN Incorporated, Seattle, Washington","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I165779595","https://openalex.org/I217937681","https://openalex.org/I2800555584"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007330428","display_name":"Michele W.L. Teng","orcid":"https://orcid.org/0000-0003-1886-9145","observed_orcids":["https://orcid.org/0000-0003-1886-9145"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michele W.L. Teng","raw_affiliation_strings":["Authors' Affiliations:\u20081Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 3Immunology in Cancer and Infection Laboratory; 4Cancer Immunoregulation and Immunotherapy Laboratory, Queensland Institute of Medical Research; 5School of Medicine, University of Queensland, Herston, Queensland, Australia; and 6AMGEN Incorporated, Seattle, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne; 2Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 3Immunology in Cancer and Infection Laboratory; 4Cancer Immunoregulation and Immunotherapy Laboratory, Queensland Institute of Medical Research; 5School of Medicine, University of Queensland, Herston, Queensland, Australia; and 6AMGEN Incorporated, Seattle, Washington","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I165779595","https://openalex.org/I217937681","https://openalex.org/I2800555584"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.3075,"has_fulltext":false,"cited_by_count":46,"citation_normalized_percentile":{"value":0.88127318,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"74","issue":"9","first_page":"2412","last_page":"2421"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.4077000021934509,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.4077000021934509,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.4047999978065491,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.12020000070333481,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-cd40-monoclonal-antibody","display_name":"anti-CD40 monoclonal antibody","score":0.9549999833106995},{"id":"https://openalex.org/keywords/anti-il-23-monoclonal-antibody","display_name":"anti-IL-23 monoclonal antibody","score":0.9959999918937683},{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":0.6809999942779541},{"id":"https://openalex.org/keywords/il-23","display_name":"IL-23","score":0.9879999756813049},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.9010000228881836},{"id":"https://openalex.org/keywords/lung-metastasis","display_name":"lung metastasis","score":0.7429999709129333},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6819999814033508},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.7720000147819519},{"id":"https://openalex.org/keywords/perforin","display_name":"perforin","score":0.7459999918937683},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7749999761581421},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6830000281333923}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5988467931747437},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5806137919425964},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.564862072467804},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5085729360580444},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5053970813751221},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4523636996746063},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44258615374565125},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.4419032633304596},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1393587291240692}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005354","descriptor_name":"Fibrosarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008546","descriptor_name":"Melanoma, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008546","descriptor_name":"Melanoma, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008748","descriptor_name":"Methylcholanthrene","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018664","descriptor_name":"Interleukin-12","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019013","descriptor_name":"CD40 Antigens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D019013","descriptor_name":"CD40 Antigens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052899","descriptor_name":"Pore Forming Cytotoxic Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053759","descriptor_name":"Interleukin-23","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D053759","descriptor_name":"Interleukin-23","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/0008-5472.can-13-1646","doi":"https://doi.org/10.1158/0008-5472.can-13-1646","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-13-1646","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:24556719","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24556719","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"pmh:oai:jupiter.its.unimelb.edu.au:11343/41513","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11343/41513","pdf_url":null,"source":{"id":"https://openalex.org/S4377196259","display_name":"Minerva Access (University of Melbourne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I165779595","host_organization_name":"The University of Melbourne","host_organization_lineage":["https://openalex.org/I165779595"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320314063","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30"},{"id":"https://openalex.org/F4320322467","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1689372518","https://openalex.org/W1929074972","https://openalex.org/W1962674786","https://openalex.org/W1981858801","https://openalex.org/W1984467626","https://openalex.org/W2004312434","https://openalex.org/W2004630197","https://openalex.org/W2006471464","https://openalex.org/W2024490058","https://openalex.org/W2026572617","https://openalex.org/W2035027025","https://openalex.org/W2039701299","https://openalex.org/W2043991982","https://openalex.org/W2062889582","https://openalex.org/W2076889715","https://openalex.org/W2084388036","https://openalex.org/W2087905758","https://openalex.org/W2091378964","https://openalex.org/W2093053402","https://openalex.org/W2098005365","https://openalex.org/W2102332546","https://openalex.org/W2102507199","https://openalex.org/W2111506773","https://openalex.org/W2117064437","https://openalex.org/W2134007339","https://openalex.org/W2137945618","https://openalex.org/W2157613900","https://openalex.org/W2167264906","https://openalex.org/W2320043569"],"related_works":["https://openalex.org/W2157613900","https://openalex.org/W2094448878","https://openalex.org/W4211163740","https://openalex.org/W2809345171","https://openalex.org/W2115855176","https://openalex.org/W1976309514","https://openalex.org/W2091095985","https://openalex.org/W2165343906","https://openalex.org/W2137591551","https://openalex.org/W2050746856"],"abstract_inverted_index":{"Tumor-induced":[0],"immunosuppression":[1],"remains":[2],"one":[3],"of":[4,31,60,89,110,142,164],"the":[5,20,56,119,161,174],"major":[6],"obstacles":[7],"to":[8,47,54,134,172],"many":[9],"potentially":[10],"effective":[11],"cancer":[12],"therapies":[13],"and":[14,27,29,51,79,108,114,168],"vaccines.":[15],"Host":[16],"interleukin":[17],"(IL)-23":[18],"suppresses":[19],"immune":[21],"response":[22],"during":[23],"tumor":[24,57,123,150],"initiation,":[25],"growth,":[26],"metastases,":[28],"neutralization":[30,154],"IL-23":[32,61,129,153],"causes":[33],"IL-12-dependent":[34],"antitumor":[35,64,72],"effects.":[36],"Here,":[37],"we":[38,125],"report":[39],"that":[40,127],"combining":[41],"agonistic":[42],"anti-CD40":[43,166],"monoclonal":[44],"antibodies":[45],"(mAb)":[46],"drive":[48],"IL-12":[49],"production":[50,130],"anti-IL-23":[52,169],"mAbs":[53,170],"counter":[55],"promoting":[58],"effects":[59,95],"has":[62],"greater":[63],"activity":[65],"than":[66],"either":[67],"agent":[68],"alone.":[69],"This":[70],"increased":[71],"efficacy":[73],"was":[74,131,146,155],"observed":[75,126],"in":[76,87,118,140,149,177],"several":[77],"experimental":[78,120],"spontaneous":[80],"lung":[81,121],"metastases":[82,122],"models":[83,88,151],"as":[84,86],"well":[85],"de":[90],"novo":[91],"carcinogenesis.":[92],"The":[93],"combination":[94],"were":[96],"dependent":[97],"on":[98],"host":[99,111],"IL-12,":[100],"perforin,":[101],"IFN-\u03b3,":[102],"natural":[103],"killer,":[104],"and/or":[105],"T":[106],"cells":[107,113,145],"independent":[109],"B":[112],"IFN-\u03b1\u03b2":[115],"sensitivity.":[116],"Interestingly,":[117],"models,":[124],"intracellular":[128],"specifically":[132],"restricted":[133],"MHC-II(hi)CD11c(+)CD11b(+)":[135],"cells.":[136],"Furthermore,":[137],"an":[138],"increase":[139],"proportion":[141],"these":[143,158],"IL-23-producing":[144],"detected":[147],"only":[148],"where":[152],"therapeutic.":[156],"Overall,":[157],"data":[159],"suggest":[160],"clinical":[162],"potential":[163],"using":[165],"(push)":[167],"(pull)":[171],"tip":[173],"IL-12/23":[175],"balance":[176],"established":[178],"tumors.":[179]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2159214533","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
